American Society of Hematology

Policy News

Policy News
Subscribe to RSS
  • Executive Action on the ACA Oct 17, 2017

    After Congress repeatedly failed to pass legislation to repeal and replace the Affordable Care Act (ACA), President Trump used the power of the executive branch to make two significant changes to the law, both of which could have a substantial impact on access to care.  


  • ASH Issues Recommendations for Pediatric Research Questions to NIH’s All of Us Research Program Sep 25, 2017

    ASH submitted comments to the NIH on hematology-related pediatric research that should be included in the NIH's All of Us research program.

  • What’s next for the ACA? Sep 07, 2017

    After spending months crafting legislation to repeal and replace the Affordable Care Act (ACA), in late July, the U.S. Senate had its chance to vote on and pass repeal legislation.  

  • NCATS Seeking Information on Opportunities and Challenges for Platform Vector Human Gene Therapy Trials in Rare Diseases Sep 01, 2017

    The National Center for Advancing Translational Sciences (NCATS) released a request for information soliciting input on the use of viral vectors as platforms for therapeutic gene delivery to specific organs or cell types, and how such platforms might be developed most efficiently in clinical trials for the treatment of multiple diseases.

  • Congress Changes Stance on ACA Repeal and Replace Jul 24, 2017

    On July 13, 2017, the U.S. Senate released an updated version of the Better Care Reconciliation Act (BCRA), legislation to repeal large provisions of the Affordable Care Act (ACA).

  • Contact Your Elected Officials in Support of CDC Funding Jun 15, 2017

    Your elected officials need to hear from you about the importance of the Prevention and Public Health Fund.

  • ACA Update Mar 09, 2017

    The House of Representatives released legislation, titled the “American Health Care Act,” to repeal the Affordable Care Act.  As written, ASH has serious concerns that this legislation will reduce overall access to coverage and treatment and would greatly impact patients with hematologic diseases and disorders.

  • DEA Eliminates Grace Period for Registration Renewal Dec 21, 2016

    Through a notice on its website, the Drug Enforcement Administration (DEA) recently announced significant changes to its registration renewal process. Effective January 1, 2017, the DEA is eliminating the informal grace period which the agency has previously allowed for registrants to renew their registrations. 

  • CMS Announces End to Medicare Part B Drug Payment Model Dec 20, 2016

    On December 15, 2016, the Centers for Medicare and Medicaid Services (CMS) announced the cancellation of Medicare Part B Drug Payment Model.  CMS initially proposed the demonstration on March 8, 2016 to test new models in how physician-administered drugs are paid under the Medicare program.

  • NHLBI Small Business Innovation Research Funding Opportunity Fosters Production of Blood Cells From Stem Cells Nov 23, 2016

    ASH is pleased to see the National Heart, Lung and Blood Institute’s (NHLBI) continuous support (RFA-HL-15-030) for the development of improved techniques to enhance the production of clinically relevant, functional stem cell-derived red blood cells or platelets.

1 of 34
back to top